Trials / Conditions / Dominant Dystrophic Epidermolysis Bullosa
Dominant Dystrophic Epidermolysis Bullosa
4 registered clinical trials studyying Dominant Dystrophic Epidermolysis Bullosa — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa NCT07016750 | Krystal Biotech, Inc. | Phase 3 |
| Recruiting | Long-Term Follow-up Protocol NCT04917887 | Krystal Biotech, Inc. | — |
| Completed | A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa NCT04917874 | Krystal Biotech, Inc. | Phase 3 |
| Completed | Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB NCT04491604 | Krystal Biotech, Inc. | Phase 3 |